New report from Access to Medicine Foundation shows what pharma companies can do to ensure the few promising antimicrobials in development reach patients on the frontlines of drug resistance

Contributed by: PR Newswire

Tags

Access-to-MedFoundat

More Like This

Debiopharm Underlines Commitment to Eradicating Antimicrobial Resistance by Sponsoring the 8th Annual World AMR Conference

PR Newswire associated0

European study shows falling prices, rising costs and shortages - findings from independent study presented during World AMR Awareness Week by Viatris and Medicines for Europe

Over 3 million children died from AMR-related infections in 2022, major study shows

Cepheid Partners with Fleming Initiative to Fight Antimicrobial Resistance (AMR)

2024 Access to Medicine Index finds that pharma companies are missing opportunities to reach more patients in low- and middle-income countries

A new report from the Access to Medicine Foundation reveals how patient-focused pharma companies' access efforts are

UK launches world-first study to assess antibiotic resistance levels in healthy dogs and cats

Pet owners are being encouraged to become ‘antibiotic champions’ this November and support the Veterinary Antibiotic Amnesty